NCT02504775View on ClinicalTrials.gov

Bioequivalence Study for Mejoral 500 Product

NACompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

August 1, 2015

Primary Completion Date

August 1, 2015

Study Completion Date

August 19, 2015

Conditions
Pain
Interventions
DRUG

Mejoral® 500 Tablets

500 mg tablet of paracetamol

DRUG

Tylenol® Caplets

500 mg tablet of paracetamol

Trial Locations (1)

14610

GSK Investigational Site, Mexico City

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT02504775 - Bioequivalence Study for Mejoral 500 Product | Biotech Hunter | Biotech Hunter